N/A
Completed N=120
Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN)
Source: ClinicalTrials.gov NCT01426581 ↗Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcomePrimary: Percentage of Participants With MDI Misuse From Baseline to 30 Days Post-Discharge — 92; 84; 11; 60 percentage
Summary
The purpose of this study is to evaluate the relative effectiveness of two different ways to teach subjects while hospitalized how to use respiratory inhalers and to follow-up after discharge home from the hospital to determine durability of the education.
Teach-to-Goal (TTG) education employs instruction followed by patient "teach-back," then repeated cycles of learning and assessment until a skill is mastered. By contrast, Brief Intervention (BI) education only consists of providing the patient with verbal and written instruction.
The investigators hypothesize that hospital-based TTG compared to BI increases a patient's ability to retain instructions on respiratory inhaler technique. The investigators will test this hypothesis separately for the MDI and Diskus® devices after discharge.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants With MDI Misuse From Baseline to 30 Days Post-Discharge |
92; 84; 11; 60 | — |
| SECONDARY Role of Health Literacy - Number of Less-Than-Adequate Health Literacy Participants With 30 Days Post Discharge Acute-Care Events |
2; 7 | — |
| SECONDARY Number of Participants With Self-Efficacy |
49; 38 | — |
| SECONDARY Symptom Control |
-1.69; -1.43 | — |
| SECONDARY Number of Participants With Acute Care Events 30 Days Post Discharge |
9; 19 | — |
Eligibility Criteria
Inclusion Criteria
- 18 years and older
- Admitting diagnosis of asthma or COPD
- Physician- diagnosed asthma, asthma/COPD, or COPD. We will enroll patients even if the primary reason for admission is not asthma or COPD (e.g., patients admitted for heart failure, but with a physician diagnosis of COPD are eligible)
- Patient will be discharged home on a Metered Dose Inhaler (MDI; e.g., albuterol)
Exclusion Criteria
- Currently in an intensive care unit
- Physician declines to provide consent
- Patient unable to provide consent (e.g., history of cognitive impairment, unable to understand English) or declines to provide consent
- Previous participant in this study
Data sourced from ClinicalTrials.gov (NCT01426581). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.